HomeCompareCNDGF vs MRK

CNDGF vs MRK: Dividend Comparison 2026

CNDGF yields 526.32% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CNDGF wins by $91498.31M in total portfolio value
10 years
CNDGF
CNDGF
● Live price
526.32%
Share price
$0.38
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$91498.37M
Annual income
$66,604,394,120.22
Full CNDGF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CNDGF vs MRK

📍 CNDGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCNDGFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CNDGF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CNDGF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CNDGF
Annual income on $10K today (after 15% tax)
$44,736.84/yr
After 10yr DRIP, annual income (after tax)
$56,613,735,002.19/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CNDGF beats the other by $56,613,726,673.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CNDGF + MRK for your $10,000?

CNDGF: 50%MRK: 50%
100% MRK50/50100% CNDGF
Portfolio after 10yr
$45749.21M
Annual income
$33,302,201,959.18/yr
Blended yield
72.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CNDGF
No analyst data
Altman Z
199.2
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CNDGF buys
0
MRK buys
0
No recent congressional trades found for CNDGF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCNDGFMRK
Forward yield526.32%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$91498.37M$56.8K
Annual income after 10y$66,604,394,120.22$9,798.13
Total dividends collected$89360.23M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CNDGF vs MRK ($10,000, DRIP)

YearCNDGF PortfolioCNDGF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$63,332$52,631.58$11,206$366.19+$52.1KCNDGF
2$379,283$311,517.85$12,650$502.35+$366.6KCNDGF
3$2,149,412$1,743,579.72$14,407$694.19+$2.14MCNDGF
4$11,534,400$9,234,529.31$16,585$967.82+$11.52MCNDGF
5$58,655,170$46,313,361.91$19,342$1,363.89+$58.64MCNDGF
6$282,868,010$220,106,977.55$22,913$1,947.19+$282.85MCNDGF
7$1,294,705,079$992,036,308.57$27,662$2,823.89+$1294.68MCNDGF
8$5,628,898,928$4,243,564,493.33$34,159$4,173.35+$5628.86MCNDGF
9$23,265,397,772$17,242,475,919.26$43,337$6,308.80+$23265.35MCNDGF
10$91,498,369,736$66,604,394,120.22$56,776$9,798.13+$91498.31MCNDGF

CNDGF vs MRK: Complete Analysis 2026

CNDGFStock

Condor Gold Plc, together with its subsidiaries, explores and develops gold and silver properties in Nicaragua. The company owns a 100% interest in the La India project that comprises 12 concessions covering an area of 588 square kilometers located in the La India Gold Mining District, Nicaragua. It also holds 100% interests in Rio Luna concession covering an area of 43 square kilometers located in Central Highlands, Nicaragua; and Estrella concession covering an area of 18 square kilometers located in southwest of Siuna, Nicaragua. The company was incorporated in 2005 and is headquartered in Godalming, the United Kingdom.

Full CNDGF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CNDGF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CNDGF vs SCHDCNDGF vs JEPICNDGF vs OCNDGF vs KOCNDGF vs MAINCNDGF vs JNJCNDGF vs ABBVCNDGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.